Drug transporters revisited

Journal of Clinical Psychopharmacology

Volumn 21, Issue 1, 2001, Pages 1-3

  Von Moltke, Lisa L ^a   Greenblatt, David J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; DEXAMETHASONE; DIGOXIN; GLYCOPROTEIN P; LOPERAMIDE; ONDANSETRON; PACLITAXEL; PROTEINASE INHIBITOR; QUINIDINE;

BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG PENETRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOPHARMACOLOGY; REVIEW;

ANIMALS; ANTIDIARRHEALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DIGOXIN; ENZYME INHIBITORS; HUMANS; LOPERAMIDE; P-GLYCOPROTEIN;

EID: 0035139846     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200102000-00001     Document Type: Review

References (35)

1. Drug transporters in psychopharmacology - Are they important?
2. Increased drug delivery to the brain by P-glycoprotein inhibition
3. Genetic analysis of the multidrug transporter
4. P-glycoprotein and multidrug resistance
5. P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
6. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
7. The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions
8. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
9. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
10. P-glycoprotein - A mediator of multidrug resistance in tumour cells
11. Can multidrug resistance mechanisms be modified?
12. P-glycoprotein and drug therapy in organ transplantation
13. Safety and efficacy of loperamide
14. Loperamide. Survey of studies on mechanism of its antidiarrheal activity
15. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea
16. Therapeutic approach to the patient with irritable bowel syndrome
17. Management of protease inhibitor-associated diarrhea
18. High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients
19. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
20. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
21. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability
22. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers
23. Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations
24. Delirium at therapeutic serum concentrations of digoxin and quinidine
25. Digitalis delirium in an elderly woman
26. Advances in the management of digoxin toxicity in the older patient
27. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine
28. Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein
29. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
30. Itraconazole decreases renal clearance of digoxin
31. P-glycoprotein system as a determinant of drug interactions: The case of digoxin-verapamil
32. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
33. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
34. Grapefruit juice activates P-glycoprotein-mediated drug transport